Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Vyleesi’s Approval Delayed By Blood Pressure Study Conducted During NDA Review
Oct 23 2019
•
By
Sue Sutter
A blood pressure study delayed the approval of AMAG's Vyleesi • Source: Shutterstock
More from Drug Review Profiles
More from Product Reviews